Protagonist Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.About PTGX
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.
CEODinesh V. Patel
CEODinesh V. Patel
Employees126
Employees126
HeadquartersNewark, California
HeadquartersNewark, California
Founded2006
Founded2006
Employees126
Employees126
PTGX Key Statistics
Market cap4.82B
Market cap4.82B
Price-Earnings ratio108.76
Price-Earnings ratio108.76
Dividend yield—
Dividend yield—
Average volume2.26M
Average volume2.26M
High today$77.62
High today$77.62
Low today$75.17
Low today$75.17
Open price$75.60
Open price$75.60
Volume1.21M
Volume1.21M
52 Week high$93.25
52 Week high$93.25
52 Week low$33.31
52 Week low$33.31
PTGX News
Nasdaq 5d
Protagonist Therapeutics Reaches Analyst Target PriceIn recent trading, shares of Protagonist Therapeutics Inc (Symbol: PTGX) have crossed above the average analyst 12-month target price of $71.54, changing hands...
Analyst ratings
93%
of 14 ratingsBuy
92.9%
Hold
7.1%
Sell
0%
People also own
Based on the portfolios of people who own PTGX. This list is generated using Robinhood data, and it’s not a recommendation.